Results suggest that SHP1 may be a potential target for muscle insulin resistance and insulin signaling during obesity, as well as the fact that it may be involved in the development of non-alcoholic fatty liver disease caused by diet-induced obesity [64,65,66]. Here, INS is linked to obesity disorder.